Perspective Therapeutics (CATX) Share-based Compensation (2010 - 2026)

Perspective Therapeutics has disclosed Share-based Compensation across 17 years of filings, most recently posting $2.6 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $2.6 million, up 21.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.4 million (up 40.67% YoY), and the FY2025 annual result was $9.0 million, up 71.73% from the prior year.
• Share-based Compensation came in at $2.6 million for Q1 2026 at Perspective Therapeutics, up from $2.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.6 million in Q1 2026 to a low of $154000.0 in Q2 2022.
• The 5-year median for Share-based Compensation is $1.0 million (2023), against an average of $1.3 million.
• Across the five-year window, Share-based Compensation jumped 771.34% in 2023 and sank 54.53% in 2024, its largest moves.
• Perspective Therapeutics' Share-based Compensation stood at $496000.0 in 2022, then jumped by 39.72% to $693000.0 in 2023, then soared by 197.26% to $2.1 million in 2024, then climbed by 12.09% to $2.3 million in 2025, then gained by 10.57% to $2.6 million in 2026.
• The last three Share-based Compensation figures came in at $2.6 million (Q1 2026), $2.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.